Northam Platinum Holdings Limited (NPTLF)

Market Cap	4.54B
Revenue (ttm)	1.61B
Net Income (ttm)	79.71M
Shares Out	n/a
EPS (ttm)	0.20
PE Ratio	56.99
Forward PE	28.39
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	1,450
Open	10.00
Previous Close	8.50
Day's Range	10.00 - 10.00
52-Week Range	6.25 - 10.00
Beta	0.87
RSI	60.58
Earnings Date	Aug 29, 2025

About Revance Therapeutics

Northam Platinum Holdings Limited, through its subsidiary, Northam Platinum Limited, engages in the production and sale of platinum group metals in South Africa, the Americas, Europe, the United Kingdom, Far East, rest of Africa, the Middle East, Australasia, and the People's Republic of China. The company explores for platinum, palladium, rhodium, gold, iridium, ruthenium, silver, nickel, copper, cobalt, and chrome deposits. It holds interests in the Booysendal mine located on the eastern limb of the Bushveld complex; the Zondereinde mine loca...

• Industry: Other Precious Metals & Mining
• Sector: Materials
• Founded: 2020
• Employees: 13,480
• Stock Exchange: OTCMKTS
• Ticker Symbol: NPTLF

Financial Performance

In 2024, Northam Platinum Holdings's revenue was 30.77 billion, a decrease of -22.21% compared to the previous year's 39.55 billion. Earnings were 1.80 billion, a decrease of -29.61%.